Glaxosmithkline Share News (GSK)

EMA adopts 'positive opinion' of GSK's RSV vaccine candidate

(Sharecast News) - GSK updated the market on its respiratory syncytial virus (RSV) vaccine candidate for older adults on Thursday, reporting that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) had adopted a positive opinion by consensus.

GSK's RSV vaccine first to get EU regulator's nod

EMA recommends authorization of first RSV vaccine

*

European shares fall as healthcare stocks hit by drug reforms

Healthcare index marks biggest decline in 15 months

*

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight.

UK shareholder meetings calendar - next 7 days

EU publishes proposed drug laws overhaul, seting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its vaccines as well as HIV and respiratory medicines.

EU publishes proposed drug laws overhaul, setting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines.

TOP NEWS: GSK quarterly sales and profit slips; confirms outlook

(Alliance News) - Brentford, London-based GSK PLC on Wednesday reported a slip in quarterly sales, but confirmed its 2023 guidance.

LONDON BRIEFING: GSK quarterly sales slip but confirms 2023 guidance

(Alliance News) - Stocks in London were set to open lower on Wednesday as worries about the US banking sector returned.

GSK Q1 beats estimates

(Sharecast News) - GSK first quarter profits and revenue both beat expectations driven by its shingles and meningitis treatments, among others.

GSK says Europe watchdog backs marketing authorisation application

(Alliance News) - GSK PLC on Tuesday said the European Medicines Agency has validated its marketing authorisation application for its dostarlimab drug, marketed as Jemperli.

GSK says EMA validates cancer drug submission

(Sharecast News) - GSK said the European Medicines Agency had validated the its submission for a potential new indication of its treatment for a type of gynaecological cancer known as mismatch repair deficient primary advanced or recurrent endometrial cancer.

UK earnings, trading statements calendar - next 7 days